前沿论文｜CELL INTELLIGENCE

The evolution of CAR therapies across oncology and autoimmunity: mechanistic insights and therapeutic innovations.

PubMed 2026/05/16 发表Int ImmunopharmacolQ1 · IF 5.6（JCR 2025）

CAR T-cells in hematologic malignancies: Advances, challenges, and future directions.

PubMed 2026/03/04 发表iScienceQ1 · IF 4.5（JCR 2025）

2025 Update of Cellular Immunotherapy for Plasma Cell Disorders.

PubMed 2025/12/23 发表Turk J HaematolQ3 · IF 1.6（JCR 2025）

CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma.

PubMed 2025/08/25 发表Int J Mol SciQ1 · IF 5.6（JCR 2025）

Current Anti-Myeloma Chimeric Antigen Receptor-T Cells: Novel Targets and Methods.

PubMed 2025/07/01 发表Balkan Med JQ1 · IF 4.5（JCR 2025）

Harnessing the potential of gene-editing technology to overcome the current bottlenecks of CAR-T cell therapy in T-cell malignancies.

PubMed 2025/03/22 发表Exp HematolQ2 · IF 2.7（JCR 2025）

Delineating MYC-Mediated Escape Mechanisms from Conventional and T Cell-Redirecting Therapeutic Antibodies.

PubMed 2024/11/11 发表Int J Mol SciQ1 · IF 5.6（JCR 2025）

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells.

PubMed 2023/09/29 发表ImmunityQ1 · IF 30.6（JCR 2025）

前沿论文 8